These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22190576

  • 1. Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes.
    de Chickera S, Willert C, Mallet C, Foley R, Foster P, Dekaban GA.
    Int Immunol; 2012 Jan; 24(1):29-41. PubMed ID: 22190576
    [Abstract] [Full Text] [Related]

  • 2. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging.
    Dekaban GA, Hamilton AM, Fink CA, Au B, de Chickera SN, Ribot EJ, Foster PJ.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013 Jan; 5(5):469-83. PubMed ID: 23633389
    [Abstract] [Full Text] [Related]

  • 3. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner.
    Joo HJ, Kim HS, Choi YS, Kim H, Kim SJ, Moon WK.
    NMR Biomed; 2012 Apr; 25(4):570-9. PubMed ID: 22009917
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
    Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S.
    J Immunol; 1999 Jan 01; 162(1):168-75. PubMed ID: 9886383
    [Abstract] [Full Text] [Related]

  • 12. Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma model.
    Pilon-Thomas S, Li W, Briggs JJ, Djeu J, Mulé JJ, Riker AI.
    J Immunother; 2006 Jan 01; 29(4):381-7. PubMed ID: 16799333
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
    Möller I, Michel K, Frech N, Burger M, Pfeifer D, Frommolt P, Veelken H, Thomas-Kaskel AK.
    J Immunother; 2008 Jun 01; 31(5):506-19. PubMed ID: 18463533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y, Huang H, Chen Z, Zong L, Xiang J.
    J Gene Med; 2003 Aug 01; 5(8):668-80. PubMed ID: 12898636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.